Skip to content
Screener

Novanta NOVT Medical Solutions — Segment Operating Income

Similar metrics at other companies

Powell Industries logo
POWLReportable Segment — Segment Operating Income
$57.58M-2.3%
Vishay Intertechnology logo
VSHSegment Operating Income
$146.55M+59.2%
Mission Produce, Inc. logo
AVOSegment Operating Income
$16.35M-1.7%
Park-Ohio Holdings logo
PKOHSegment Operating Income
$32.8M+17.6%
Fortrea Holdings Inc. logo
FTREClinical Services Segment — Segment Operating Income
$39.9M+57.1%
Fortrea Holdings Inc. logo
FTREClinical Services Segment — Segment Operating Income
$21.85M-8.0%

Other financials

Income statement

See full
Revenue$265.8M+10.3%
Gross profit$120.9M+13.3%
Operating income$18.1M+21.1%
Net income$12.5M+179%
EPS (diluted)$0.30+150%

Balance sheet

See full
Cash & equivalents$718.7M+554%
Total debt$285.6M-44.5%
Total equity$1.6B+102%
Total assets$2.1B+41.6%

Cash flow

See full
Operating cash flow$64.9M+331%
CapEx$7.5M+120%
Free cash flow$57.5M+392%

Valuation

See full
Market cap$5.82B+42.2%
Enterprise value$5.38B+19.7%
P/E94.2×+27.5×
P/S5.7×+1.4×

Profitability

See full
Gross margin44.5%-0.2pp
Operating margin9%-2.2pp
Net margin6%-0.4pp
FCF margin11.1%-1.2pp

Returns & leverage

See full
Return on equity5.1%-3.1pp
Debt / equity0.2×-0.5×
Current ratio4.6×+2.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept novt:SegmentOperatingIncome.

The source filing: Novanta’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335404
Line itemThree Months Ended July 3, 2026 / Automation Enabling TechnologiesThree Months Ended July 3, 2026 / Medical SolutionsThree Months Ended July 3, 2026 / TotalSix Months Ended July 3, 2026 / Automation Enabling TechnologiesSix Months Ended July 3, 2026 / Medical SolutionsSix Months Ended July 3, 2026 / Total
Selling, general and administrative20,78416,58540,67332,891
Amortization of purchased intangible assets2,7043,7114,8237,366
Restructuring, acquisition, and related costs2,0201,7532,5832,993
Segment operating income36,59213,60750,19967,74530,33398,078
Unallocated costs(32,138)(52,478)
Interest income (expense), net(1,106)(2,949)
Other income (expense), net(1,057)(399)
Income before income taxes$36,592$13,607$15,898$67,745$30,333$42,252

Item 1. Financial Statements

FAQ

What is Novanta's medical solutions — segment operating income?
Novanta (NOVT) reported medical solutions — segment operating income of $13.61M in Q2 2026.
How has Novanta's medical solutions — segment operating income changed year-over-year?
Novanta's medical solutions — segment operating income increased by 105.4% year-over-year, from $6.63M to $13.61M.
What is the long-term trend for Novanta's medical solutions — segment operating income?
Over 3 years (2022 to 2025), Novanta's medical solutions — segment operating income has grown at a 3.0% compound annual growth rate (CAGR), from $46.87M to $51.17M.
What does medical solutions — segment operating income mean?
This is the primary measure of profitability for the business segment, calculated as revenue minus operating expenses, excluding interest and taxes. It serves as a key indicator of the segment's ability to generate profit from its core business activities. Investors use this to assess the operational efficiency and competitive strength of the specific business unit.

Ask your AI about Novanta's medical solutions — segment operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude